Ann: Prominent biotech investor leads investment in Race, page-102

Yes I see now the 2 points being made. My bad for assuming the major point was people selling out at nearly 3 year lows.
I guess as shareholders we could easily agree to only ask science based questions and all agree to expect to be ignored, or if you prefer, not replied too if we go down the blame game route of why we are where we are. Let's see how long it takes before we need our CEO to either explain a historical decision or correct a wrong assumption, I seem to be reading a lot of corrections.
Bring on RC220 so we can get back to the science.

GL @Titans19 may the tide turn quickly for all of us.